Accuracy of near-patient blood tests for Helicobacter pylori

European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).

The Journal of hospital infection·2022

Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile.

Journal of clinical microbiology·2021

Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2.

Infection prevention in practice·2021

The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model.

The Journal of hospital infection·2021

Protecting the Microbiota.

The Journal of infectious diseases·2021

Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.

The Journal of antimicrobial chemotherapy·2020

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Understanding peripheral arterial disease in the current era.

Lancet (London, England)·2026

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Lancet (London, England)·2026

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Lancet (London, England)·2026

Duration of same-species antimicrobial non-susceptibility persistence in urinary gram-negative bacilli: a 12-year within-patient cohort study.

Frontiers in cellular and infection microbiology·2026

Clinical characteristics of microbiologically inappropriate empiric antibiotics in emergency department patients with bacteremia: A descriptive study.

Medicine·2026

The Therapeutic Potential of Phages in Multi-Drug Resistance Infections and Future Directions.

Viruses·2026

Yeokwisan Attenuates Reflux-Induced Esophageal Injury and Suppresses Macrophage Inflammatory Responses Associated with MAPK/PI3K-Akt and NF-κB/COX-2 Signaling.

Pharmaceuticals (Basel, Switzerland)·2026

Antibiotic-Free Strategies for Managing Antimicrobial-Resistant Infections.

Pharmaceutics·2026

ESBL-Producing Klebsiella pneumoniae Bacteraemia with Renal Micro-Abscesses Treated with Cefepime-Enmetazobactam in a Neutropenic Allogeneic Transplant Recipient.

Pathogens (Basel, Switzerland)·2026

Related Experiment Videos

Accuracy of near-patient blood tests for Helicobacter pylori

Related Concept Videos

European survey on the current surveillance practices, management guidelines, treatment pathways and heterogeneity of testing of Clostridioides difficile, 2018-2019: results from The Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI).

Comparison of Whole-Genome Sequence-Based Methods and PCR Ribotyping for Subtyping of Clostridioides difficile.

Evidence review of physical distancing and partition screens to reduce healthcare acquired SARS-CoV-2.

The effect of intestinal microbiota dysbiosis on growth and detection of carbapenemase-producing Enterobacterales within an in vitro gut model.

Protecting the Microbiota.

Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Faecal microbiota transplantation in irritable bowel syndrome (REFIT2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Understanding peripheral arterial disease in the current era.

Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

Duration of same-species antimicrobial non-susceptibility persistence in urinary gram-negative bacilli: a 12-year within-patient cohort study.

Clinical characteristics of microbiologically inappropriate empiric antibiotics in emergency department patients with bacteremia: A descriptive study.

The Therapeutic Potential of Phages in Multi-Drug Resistance Infections and Future Directions.

Yeokwisan Attenuates Reflux-Induced Esophageal Injury and Suppresses Macrophage Inflammatory Responses Associated with MAPK/PI3K-Akt and NF-κB/COX-2 Signaling.

Antibiotic-Free Strategies for Managing Antimicrobial-Resistant Infections.

ESBL-Producing Klebsiella pneumoniae Bacteraemia with Renal Micro-Abscesses Treated with Cefepime-Enmetazobactam in a Neutropenic Allogeneic Transplant Recipient.

Related Experiment Videos

Accuracy of near-patient blood tests for Helicobacter pylori

Related Concept Videos

Related Articles